Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity

European Journal of Immunology

Volumn 32, Issue 9, 2002, Pages 2562-2569

  Ostler, Tobias ^a   Ehl, Stephan ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CD8+ T cell; Lung; Memory; Protective immunity; Virus

Indexed keywords

ANTIBODY; CD8 ANTIGEN; INTERFERON; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOMODULATION; IN VIVO STUDY; INTERFERON PRODUCTION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVARY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; TIME FACTORS; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0036742233     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4     Document Type: Article

References (49)

1. Taylor, G., Stott, E. J., Bew, M., Fernie, B. F., Cote, P. J., Collins, A. P., Hughes, M. and Jebbett, J., Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 1984. 52: 137-142.
2. Prince, G. A., Horswood, R. L. and Chanock, R. M., Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol. 1985. 55: 517-520.
3. The IMPACT RSV Study Group, Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998. 102: 531-537.
4. Groothuis, J. R., Simoes, E. A., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C. and et al., Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 1993. 329: 1524-1530.
5. Stott, E. J., Ball, L. A., Young, K. K., Furze, J. and Wertz, G. W., Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge. J. Virol. 1986. 60: 607-613.
6. Olmsted, R. A., Elango, N., Prince, G. A., Murphy, B. R., Johnson, P. R., Moss, B., Chanock, R. M. and Collins, P. L., Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. USA 1986. 83: 7462-7466.
7. Elango, N., Prince, G. A., Murphy, B. R., Venkatesan, S., Chancock, R. M. and Moss, B., Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proc. Natl. Acad. Sci. USA 1986. 83: 1906-1910.
8. Glezen, W. P., Paredes, A., Allison, J. E., Taber, L. H. and Frank, A. L., Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levels. J. Pediatr. 1981. 98: 708-715.
9. Glezen, W. P., Taber, L. H., Frank, A. L. and Kasel, J. A., Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child 1986. 140: 543-546.
10. Crowe, J. E., Jr., Firestone, C. Y. and Murphy, B. R., Passively acquired antibodies suppres humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J. Immunol. 2001. 167: 3910-3918.
11. Murphy, B. R., Alling, D. W., Snyder, M. H., Walsh, E. E., Prince, G. A., Chanock, R. M., Hemming, V. G., Rodriguez, W. J., Kim, H. W., Graham, B. S. and et al., Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J. Clin. Microbiol. 1986. 24: 894-898.
12. Murphy, B. R., Olmsted, R. A., Collins, P. L., Chanock, R. M. and Prince, G. A., Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J. Virol. 1988. 62: 3907-3910.
13. Wright, P. F., Karron, R. A., Belshe, R. B., Thompson, J., Crowe, J. E., Jr., Boyce, T. G., Halburnt, L. L., Reed, G. W., Whitehead, S. S., Anderson, E. L., Wittek, A. E., Casey, R., Eichelberger, M., Thumar, B., Randolph, V. B., Udem, S. A., Chanock, R. M. and Murphy, B. R., Evaluation of a live-cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infect. Dis. 2000. 182: 1331-1342.
14. Brandt, C., Power, U. F., Plotnicky-Gilquin, H., Huss, T., Nguyen, T., Lambert, P. H., Binz, H. and Siegrist, C. A., Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. J. Infect. Dis. 1997. 176: 884-891.
15. Siegrist, C. A., Plotnicky-Gilquin, H., Cordova, M., Berney, M., Bonnefoy, J. Y., Nguyan, T. N., Lambert, P. H. and Power, U. F., Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies. J. Infect. Dis. 1999. 179: 1326-1333.
16. Hall, C. B., Walsh, E. E., Long, C. E. and Schnabel, K. C., Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 1991. 163: 693-698.
17. Henderson, F. W., Collier, A. M., Clyde, W. A., Jr. and Denny, F. W., Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 1979. 300: 530-534.
18. Graham, B. S., Bunton, L. A., Wright, P. F. and Karzon, D. T., Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 1991. 88: 1026-1033.
19. Cannon, M. J., Openshaw, P. J. and Askonas, B. A., Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 1988. 168: 1163-1168.
20. Hall, C. B., Powell, K. R., MacDonald, N. E., Gala, C. L., Menegus, M. E., Suffin, S. C. and Cohen, H. J., Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 1986. 315: 77-81.
21. Fishaut, M., Tubergen, D. and McIntosh, K., Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J. Pediatr. 1980. 96: 179-186.
22. + T cells, while that induced by Vac-F or Vac-G recombinant is mediated by antibodies. J. Virol. 1992. 66: 1277-1281.
23. Connors, M., Collins, P. L., Firestone, C. Y. and Murphy, B. R., Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 1991. 65: 1634-1637.
24. Plotnicky-Gilquin, H., Robert, A., Chevalet, L., Haeuw, J. F., Beck, A., Bonnefoy, J. Y., Brandt, C., Siegrist, C. A., Nguyen, T. N. and Power, U. F., CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment. J. Virol. 2000. 74: 3455-3463.
25. + T-cell memory in the respiratory tract. Nature Med. 2002. 8: 54-60.
26. Chang, J., Srikiatkhachorn, A. and Braciale, T. J., Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J. Immunol. 2001. 167: 4254-4260.
27. Schlender, J., Walliser, G., Fricke, J. and Conzelmann, K. K., Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol. 2002. 76: 1163-1170.
28. Ostler, T., Schamel, K., Hussell, T., Openshaw, P., Hausmann, J. and Ehl, S., An improved protocol for measuring cytotoxic T cell activity in anatomic compartments with low cell numbers. J. Immunol. Methods 2001. 257: 155-161.
29. Openshaw, P. J., Anderson, K., Wertz, G. W. and Askonas, B. A., The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection. J. Virol. 1990. 64: 1683-1689.
30. Zinkernagel, R. M., Cooper, S., Chambers, J., Lazzarini, R. A., Hengartner, H. and Arnheiter, H., Virus-induced autoantibody response to a transgenic viral antigen. Nature 1990. 345: 68-71.
31. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J. Immunol. 1991. 146: 4301-4307.
32. Bangham, C. R., Openshaw, P. J., Ball, L. A., King, A. M., Wertz, G. W. and Askonas, B. A., Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 1986. 137: 3973-3977.
33. Goulder, P. J., Lechner, F., Klenerman, P., McIntosh, K. and Walker, B. D., Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J. Virol. 2000. 74: 7694-7697.
34. Brandenburg, A. H., de Waal, L., Timmerman, H. H., Hoogerhout, P., de Swart, R. L. and Osterhaus, A. D., HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J. Virol. 2000. 74: 10240-10344.
35. Ostler, T., Hussell, T., Surh, C. D., Openshaw, P. and Ehl, S., Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol. 2001. 31: 2574-2582.
36. + T cells in primary and secondary influenza pneumonia. Immunity 1998. 8: 683-691.
37. + T cell responses. J. Immunol. 2001. 166: 4627-4633.
38. Ehl, S., Klenerman, P., Aichele, P., Hengartner, H. and Zinkernagel, R. M., A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 1997. 27: 3404-3413.
39. + lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J. Virol. 1993. 67: 1044-1049.
40. + lymphocytes. J. Med. Virol. 1991. 35: 165-173.
41. Nicholas, J. A., Rubino, K. L., Levely, M. E., Adams, E. G. and Collins, P. L., Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. J. Virol. 1990. 64: 4232-4241.
42. Graham, B. S., Bunton, L. A., Rowland, J., Wright, P. F. and Karzon, D. T., Respiratory syncytial virus infection in anti-mutreated mice. J. Virol. 1991. 65: 4936-4942.
43. Macpherson, A. J., Lamarre, A., McCoy, K., Harriman, G. R., Odermatt, B., Dougan, G., Hengartner, H. and Zinkernagel, R. M., IgA production without mu or delta chain expression in developing B cells. Nature Immunol. 2001. 2: 625-631.
44. Siegrist, C. A., Barrios, C., Martinez, X., Brandt, C., Berney, M., Cordova, M., Kovarik, J. and Lambert, P. H., Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 1998. 28: 4138-4148.
45. Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., Forthani, B., Beeler, J., Audet, S., Maldonado, Y. and Arvin, A. M., Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J. Infect. Dis. 2001. 184: 817-826.
46. Kitamura, D., Roes, J., Kuhn, R. and Rajewsky, K., A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin nu chain gene. Nature 1991. 350: 423-426.
47. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. and Waldmann, H., Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984. 312: 548-551.
48. Ostler, T. and Ehl, S., A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinphilia. J. Immunol. Methods 2002, in press.
49. Kulkarni, A. B., Collins, P. L., Bacik, I., Yewdell, J. W., Bennink, J. R., Crowe, J. E., Jr. and Murphy, B. R., Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 1995. 69: 1261-1264.